New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia
Dose-Response Effects of Exercise on Glucose-Lowering Medications for Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial - Mayo Clinic Proceedings
Japanese Clinical Practice Guideline for Diabetes 2019 - Araki - 2020 - Journal of Diabetes Investigation - Wiley Online Library
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
Updated ADA, EASD 2018 Guidelines for Managing Hyperglycemia
Management Of Type 2 Diabetes: Selecting Amongst Available Pharmacological Agents - Endotext - NCBI Bookshelf
2018ADA和EASD有關2型糖尿病治療標準共識之評論報告_Informa生命科學智庫- 微文庫
JCM | Free Full-Text | Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes | HTML
Glucose-lowering medication in type 2 diabetes: overall approach. - ppt download
Glucose-lowering rx in T2DM approach - UpToDate
Summary of the overall approach to glucose-lowering medications in type... | Download Scientific Diagram
Glucose-lowering medication in type 2 diabetes: overall approach | Download Scientific Diagram
Clinical Guidelines – Diabetologia
Dietary and nutritional approaches for prevention and management of type 2 diabetes | The BMJ
RACGP - Medical management of glycaemia
Type II diabetes mellitus: a review on recent drug based therapeutics - ScienceDirect
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
Patient-centred care in type 2 diabetes mellitus – Key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report - Diabetes Research and Clinical Practice
Glucose-lowering medication in type 2 diabetes: overall approach | Download Scientific Diagram
Molecules | Free Full-Text | Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs | HTML
What the studies say about targets for glycaemic control (including hypoglycaemia)
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes | NEJM
Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map - The Lancet Diabetes & Endocrinology
Medications in Diabetes - Mind The Bleep
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary - Endocrine Practice
